CGEN · Compugen Ltd
$2.28
-0.10 (-4.20%)
At close · Aug 5
Market Cap
$217.07M
Shares
94.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.28
Open$2.35
Day$2.26–2.37
52W$1.30–3.24
Avg vol 30d260K
Short int3.0M · 3.2% float · 11.2d
Short vol27%
Last earningsAug 3, 2026
DataJan 2020–Aug 2026
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.46
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
+1%
above
RSI (14)
47
neutral
MACD trend
Negative
52-week position
51%
mid-range
Momentum
relative strength
1-month return
−5%
trailing
6-month return
+33%
trailing
YTD return
+49%
this year
Relative strength
+22%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Distributing
25 of 79 funds reported for Jun 30 · net -79.2K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.20% of float · ▲ +8.2% MoM · 11.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
79 holders — near 3-yr high, broad support
Squeeze score
74
high risk · 0–100
Fundamentals
Revenue growth
+161%
Y/Y
Gross margin
87%
expanding
EPS growth
+338%
Y/Y
Free cash flow
$31.3M
Balance sheet
$90.6M
net cash
Quant / Vol
risk profile
Volatility
69%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
51%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Distributing
25 of 79 funds reported for Jun 30 · net -79.2K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.20% of float · ▲ +8.2% MoM · 11.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
79 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $2 · 51%
52-wk high $3
vs 200-day avg +10%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CGEN
this stock
Compugen Ltd
|
$217.07M | +49.0% | +346.1% | — | 3.2% |
|
ONC
BeOne Medicines Ltd.
|
$484.13B | +7.8% | +22179.2% | 744.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$119.47B | +6.9% | +46.2% | 27.5 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.13B | -0.2% | +20.8% | 19.0 | 3.4% |
|
ARGX
Argenx SE
|
$54.30B | +3.2% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CGEN | +1.8% | -5.4% | +33.3% | -3.0% | +49.0% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -3.7% | -8.7% | +22.1% | -6.0% | +36.1% |
Key facts
CIK
1119774
CUSIP
M25722105
13F (30d)
25 filings
21 filers
Visit website
Investor relations